Fusion Antibodies Plc FAB

LSE · United Kingdom · Health Services

GBp 11.500.00 (0.00%)

Market closed· Oct 1, 2026, 3:10 PM UTC· GBp · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Fusion Antibodies Plc FAB

LSE · United Kingdom · Health Services

GBp 11.500.00 (0.00%)

Market closed· Oct 1, 2026, 3:10 PM UTC· GBp · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-4.17% · 6MFull-screen chart

Open GBp 0.00High GBp 11.50Low GBp 11.50Close GBp 11.50Volume 20.00K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: GBp 11.50
Volume: 20.00K
Market cap: £14.39M
Next earnings date: 2026-12-07
Avg. volume (1Y): 573.42K

Performance

1 week

+2.68%

1 month

-6.12%

3 months

-4.17%

6 months

-11.54%

Year to date

-14.81%

1 year

-31.34%

Total return, dividends included.

Company profile

Sector: Health Services
Industry: Medical/Nursing Services
Country: United Kingdom
Exchange: LSE
Shares outstanding: 125.16M
ISIN: GB00BDQZGK16
Beta: 1.81

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMay 14, 2026

UK Penny Stocks To Consider In May 2026

The UK market has recently faced challenges, with the FTSE 100 index experiencing a downturn following weak trade data from China, highlighting global economic interdependencies. Despite such broader market fluctuations, investors often seek opportunities in smaller or newer companies that can offer unique growth potential. While the term "penny stocks" might seem outdated, these investments can still provide value when they possess strong financial foundations and stability.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.